Skip to content
FrontierPicks

Dormant

LOVE · The Lovesac Company

Conviction · LOW Earnings inflection Catalyst · Consumer discretionary rotation

Last analysed ·

Resolved Graded and closed 2026-09-18 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-19 and is not part of the scored record.

Current thesis

The 2026-08-27 notice made the binary real: Q2 FY27 lands before the open on 2026-09-10 against a company bar of $157–166M net sales and −$4M to +$2M adjusted EBITDA. Price closed $16.69 on 2026-09-04, under the 50-day at $16.95 and above a rising 200-day at $15.00, while the short base decayed again to 2.81M shares / 26.34% of float, leaving a maturing setup whose squeeze asymmetry keeps thinning into the print.

Kill line

A weekly close below $15.50 forfeits the summer range and leaves only the rising 200-day near $15.00 beneath; secondary: Q2 FY27 net sales printing under the company's own $157M low end on 2026-09-10, or FY27 net sales guided beneath the $700M floor.

Pick status

Invalidated resolved published kill line fired How this is scored →

Latest analysis and events for LOVE —

As of 19 September 2026, the latest FrontierPicks analysis for The Lovesac Company (LOVE): The 2026-08-27 notice made the binary real: Q2 FY27 lands before the open on 2026-09-10 against a company bar of $157–166M net sales and −$4M to +$2M adjusted EBITDA. Price closed $16.69 on 2026-09-04, under the 50-day at $16.95 and above a rising 200-day at $15.00, while the short base decayed again to 2.81M shares / 26.34% of float, leaving a maturing setup whose squeeze asymmetry keeps thinning into the print.

Kill line: A weekly close below $15.50 forfeits the summer range and leaves only the rising 200-day near $15.00 beneath; secondary: Q2 FY27 net sales printing under the company's own $157M low end on 2026-09-10, or FY27 net sales guided beneath the $700M floor.

Next dated event on file: — catalyst in 4d.

Current Thesis

The Lovesac Company’s recovery case requires a reclaim of the former $15.50 research threshold after September’s guidance cut; a daily close below the September 18 reference close of $13.50 would invalidate that recovery attempt. This is a new, low-conviction hypothesis: the earlier earnings thesis failed when management reduced its fiscal 2027 sales outlook on 2026-09-10.

The company now forecasts fiscal 2027 revenue of $690–710 million, versus $700–740 million reaffirmed on 2026-06-15. That breaches the previous dossier’s fundamental condition. September 10 results.

The inference is that the narrative is dead in its previous form — the guidance reduction on 2026-09-10 and the adjusted market close of $13.50 on 2026-09-18 defeated its earnings and price conditions. A recovery remains unconfirmed; the old threshold is a test of repair, not established support.

Bullish and bearish views on The Lovesac Company

The model's bull view on The Lovesac Company (LOVE), in brief: Quarterly sales met the bar. Revenue of $161.2 million for the quarter ended 2026-08-02 fell within management’s previously published $157–166 million range. September 10 results. Corporate liquidity improved sequentially. Company cash reached $68.8 million on 2026-08-02… The bear view: Refunds complicate the profit reading. For the quarter ended 2026-08-02, reported gross margin was 68.4%; management disclosed 56.0% excluding tariff recoveries. Comparable sales declined 1.9%. September 10 results. Analyst expectations moved downward. Investing.com reported… Both cases follow in full.

Bull Case

  • Quarterly sales met the bar. Revenue of $161.2 million for the quarter ended 2026-08-02 fell within management’s previously published $157–166 million range. September 10 results.
  • Corporate liquidity improved sequentially. Company cash reached $68.8 million on 2026-08-02, compared with the $57.0 million reported for the preceding quarter; the credit line was undrawn. September 10 results.
  • Product expansion has a date. Lovesac announced its Snugg collection expansion on 2026-09-15. The announcement establishes product activity; it does not establish incremental demand. Company news listing.

Bear Case

  • Refunds complicate the profit reading. For the quarter ended 2026-08-02, reported gross margin was 68.4%; management disclosed 56.0% excluding tariff recoveries. Comparable sales declined 1.9%. September 10 results.
  • Analyst expectations moved downward. Investing.com reported Canaccord’s target reduction to $20 from $22 on 2026-09-10 and DA Davidson’s reduction to $18 from $20 on 2026-09-11. These are attributed analyst forecasts, not evidence that either market price will be reached. Canaccord report, DA Davidson report.

Setup & Price Structure

The supplied adjusted daily series records a $13.50 close on 2026-09-18, 27.8% below its $18.70 trailing-year high, and a three-month price decline of 3.6%. The 14-day relative strength index was 33.9. Those observations establish weak momentum; they do not establish a bottom.

The proposed recovery succeeds on a weekly close above $15.50 before a daily close below $13.50. The former number is the historical research threshold published on 2026-09-05; the latter is the measured 2026-09-18 close, not an independently established support shelf. Current moving-average values are missing.

The 2026-09-05 StockAnalysis snapshot recorded short interest at 26.34% of float and 12.65 days to cover. Those are historical observations, not verified post-earnings positioning. The available evidence cannot establish whether the September decline involved increased shorting, covering or reduced long demand.

Catalyst Calendar (next 30 days)

  • 2026-09-24 — Short-interest publication. The Financial Industry Regulatory Authority’s schedule assigns this publication to the 2026-09-15 settlement date, capturing positioning after the September earnings release. It replaces the earlier dossier’s estimated September 25 date. Reporting calendar.
  • 2026-10-09 — Short-interest publication. The scheduled release covers settlement on 2026-09-30 and provides a subsequent positioning observation. Neither release alone establishes investor motive. Reporting calendar.

No company-confirmed earnings date was identified for 2026-09-19 through 2026-10-19. The September 10 earnings event has elapsed. Company calendar.

What Would Change Our Mind

Failure to retain the September 18 reference close would end the recovery hypothesis: a daily close below $13.50 is its published invalidation. A weekly close above the former $15.50 threshold before that breach would satisfy the defined price-repair case. It would not retrospectively reverse the September guidance failure.

Correlation Notes

This remains a single-company setup: the coverage context dated 2026-09-19 assigns Lovesac to no active theme cluster. No measured peer or index correlation series is supplied, so a consumer-discretionary or small-cap rotation cannot be credited with explaining the price move.

The analyst reports dated 2026-09-10 and 2026-09-11 cluster around the company’s earnings release. That establishes event-focused professional coverage; the sample is too small to support a retail-crowding or broader participation claim.

Notes

  • Small float: 10.68M shares of 14.64M outstanding. Gap risk both ways and thin liquidity around any single-holder flow.
  • Fiscal year ends in early February, so FY27 spans roughly Feb 2026 to Jan 2027; quarter labels do not line up with calendar quarters.
  • Sourcing shifted from China to Vietnam, Malaysia and Indonesia, where duty rates roughly doubled; the tariff exposure was relocated, not removed.
  • CFO transition effective 2026-06-15 (Keith Siegner out, Andrew Farag in). Q2 FY27 is the new CFO's first full reported quarter.
  • 'Earnings Scheduled For July 15, 2026' is a generic Benzinga calendar-feed tag, not a Lovesac report. Q1 FY27 printed 2026-06-11.
  • Share repurchase authorization stands at roughly $54.1M after a $40M expansion authorized 2026-03-26.

Related · shared themes

See also · stocks to watch